Background: We aimed to investigate mucosal immunity related to forkhead box P3 (FOXP3 + ) regulatory T (Treg) cells, T helper 17 (Th17) cells and cytokines in pediatric inflammatory bowel disease (IBD). Methods: Mucosal tissues from terminal ileum and colon and serum samples were collected from twelve children with IBD and seven control children. Immunohistochemical staining was done using anti-human FOXP3 and anti-RORγt antibodies. Serum levels of cytokines were analyzed using a multiplex assay covering interleukin (IL)-1β, IL-4, IL-6, IL-10, IL-17A/F, IL-21, IL-22, IL-23, IL-25, IL-31, IL-33, interferon (IFN)-γ, soluble CD40L, and tumor necrosis factor-α.
INTRODUCTION
Inflammatory bowel disease (IBD) is an autoimmune disease resulting from chronic and inappropriate inflammatory response to intestinal microbes affected by environmental factors and genetic susceptibility of host. 1-3 Forkhead box P3 (FOXP3 + ) regulatory T (Treg) cells and T helper 17 (Th17) cells possess anti-inflammatory and pro-inflammatory effects, respectively, in autoimmune diseases. 1,4 It has been suggested that the loss of balance between these regulatory and effector T cells can lead to the development of Crohn's disease and ulcerative colitis. 4, 5 It is known that FOXP3 + Treg cells are increased in inflamed mucosa of IBD. 6, 7 Gil et al. 8 have reported that FOXP3 + Treg cells are increased in the lamina propria (LP) and lymphoid aggregates of follicles (LF) in the lesion of Crohn's disease. Although FOXP3 + Treg cells are increased in the lesion of IBD, they have normal regulatory functions. Why these cells fail to regulate inflammation in IBD is currently unknown. 9 Th17 cells might also be increased in inflamed mucosa of IBD. 10 Cytokines play crucial roles in the pathogenesis of IBD. 11 Various cytokines produced by innate immune cells and T cells have pro-inflammatory or anti-inflammatory functions. 11, 12 Cytokines made by innate immune cells can recruit naïve CD4 + T cells and let them differentiate into effector T cells, such as Th1, Th2, Th17, FOXP3 + Treg, and follicular helper T (Tfh) cells. 11 Cytokines excreted by differentiating naïve CD4 + T cells after antigen presenting to innate immune cells can stabilize and polarize themselves into specified effector T cells. 11 Finally, effector T cells will make signature cytokines that are mediators with specified roles. 11 The objective of this study was to investigate mucosal immunity related to Treg cells and Th17 cells and perform cytokine analysis in pediatric IBD.
METHODS
Among 37 candidate children who visited Jeju National University Hospital from April 2015 to December 2017, 12 children with IBD (9 with Crohn's disease and 3 with ulcerative colitis) and 7 healthy children as controls were enrolled. Their peripheral blood samples were collected. Serum was separated from the sample and stored at −80.0°C. Mucosal tissue was collected and soaked in 4% paraformaldehyde solution. All patients were on the stage of initial diagnosis or aggravation of IBD. Exclusion criteria were patients with mucosal healing state of IBD or any other underlying disease such as chronic granulomatous disease and bacterial enterocolitis. Their mean age (mean ± standard deviation [SD]) was 12.7 ± 0.8 years old in the control group, 14.9 ± 1.5 years old in the Crohn's disease group, and 15.8 ± 0.7 years old in ulcerative colitis group (Table 1) .
Immunohistochemical staining
Paraffin-embedded sections were deparaffinized and dehydrated. Antigen retrieval was then performed in citrate buffer (pH 6.0) for 20 minutes using a microwave. Next, sections were incubated in 0.3% hydrogen peroxide and horse serum of Vector Elite ABC Kit (Vector Laboratories, Burlingame, CA, USA) to block endogenous peroxidase and unspecific responses. Anti-human FOXP3 (mouse monoclonal antibody, dilution 1:200; Abcam, Cambridge, UK) or anti-RORγ (rabbit polyclonal antibody, dilution 1:100; GeneTex Inc., CA, USA) was used as primary antibody. , and tumor necrosis factor (TNF)-α. Serum preparation was done one day before the multiplex assay. Serum samples of patients and control that were stored at −80.0°C were thawed at room temperature and then centrifuged at 15,000 rpm for 15 minutes at 4.0°C. Then 100 µL of supernatant from the each sample was transferred to a 96-well plate and stored at 4.0°C. Laboratory procedures were then performed following the manufacturer's instructions. After making pre-mixed standard (S) from S1 to S8 with one fourth dilution each 7 steps, Th17 15-plex magnet beads (1X) from 20X was prepared by dilution using assay buffer. The standard and serum samples were stabilized at the room temperature for 20 minutes. Then 50 µL of 15-plex beads (1X) was transferred to wells. Two times of washing with 100 µL of wash buffer were done by adding buffer to wells. After placing the 96-well plate to a magnet holder, the buffer was taken out. After transferring 50 µL of standard and samples to the wells of the plate, the plate was sealed with sealing tape and wrapping with an aluminum foil followed by incubation on a shaker (1,100 rpm) at room temperature for 60 minutes. Initial Dx./aggravation 7/2 1/2 FGIDs 7 IBD = inflammatory bowel disease, PCDAI = pediatric Crohn's disease activity index, PUCAI = pediatric ulcerative colitis activity index, CRP = carbohydrate reactive protein, ANCA = anti-neutrophil cytoplasmic antibody, ASCA = anti-saccharomyces cerevisiae antibody, ANA = anti-nuclear antibody, Dx. = diagnosis, FGIDs = functional gastrointestinal diseases including irritable bowel syndrome and functional abdominal pain.
Cytokine analysis with multiplex assay
After peeling off the sealing tape, three times of washing (100 µL of wash buffer each) were done. Then 25 µL of detection antibody (1X) was transferred to each well. After sealing the plate with sealing tape and wrapping it with aluminum foil, the plate was placed on a shaker (1,100 rpm) at room temperature for 30 minutes. After peeling off the sealing tape, three times of washing (100 µL of wash buffer each time) were done. After vigorous vortexing streptavidin-PE (1X), 50 µL of the solution was added to each well. After sealing the plate with sealing tape and wrapping it with aluminum foil, incubation was done on a shaker (1,100 rpm) at room temperature for 10 minutes. After peeling off the sealing tape, three times of washing with 100 µL of wash buffer each time was done. Then 125 µL of assay buffer was added to each well and the plate was covered with sealing tape. The plate was placed on a shaker (1,100 rpm) at room temperature for 30 seconds. Finally, the plate was transferred to a Bio-Plex Reader (Bio-Rad, CA, USA) for reading.
Statistical analyses
Statistical analysis was done using SPSS version 18.0 (SPSS Inc., Chicago, IL, USA). Results are presented as mean ± standard error or mean ± SD for each group. Statistical comparison between two groups and three groups was done using Student's t-test and Kruskall-Wallis test, respectively. Statistical significance was considered at P < 0.05.
Ethics statement
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RESULTS

Immunohistochemical staining
In immunohistochemical staining for FOXP3 + Treg cells in the LP of the terminal ileum (P < 0.05) and cecum (P = 0.06), the frequency of Treg cells was significantly higher in the terminal ileum of Crohn's disease group than that in the control (Fig. 1) . In immunohistochemical staining of FOXP3 + Treg cells for LF of the terminal ileum, there was no significant difference between Crohn's disease group and the control (Fig. 2) . Although the frequency of RORγt + T cells polarizing Th17 cells in the terminal ileum of Crohn's disease group tended to be higher than that in the control, the difference between the two was not statistically significant (Fig. 3) .
Cytokine analysis with multiplex assay
Results of multiplex assay are shown as Fig. 4 . The results revealed that serum concentrations of IL-4 (9.6 ± 1.5 vs. 12.7 ± 3.0 pg/mL; P = 0.013), IL-21 (14.9 ± 1.5 vs. 26.4 ± 9.1 pg/mL; P = 0.006), IL-33 (14.3 ± 0.9 vs. 19.1 ± 5.3 pg/mL; P = 0.002), and IFN-γ (15.2 ± 5.9 vs. 50.2 ± 42.4 pg/mL; P = 0.002) in Crohn's disease were significantly lower than those in the control (Fig. 4A, D, F, and G) . However, serum concentration of IL-6 (119.1 ± 79.6 vs. 52.9 ± 39.1 pg/mL; P = 0.030) in Crohn's disease was higher than that in the control (Fig. 4B) . Serum concentrations of IL-17A (64.2 ± 17.2 vs. 28.3 ± 10.0 pg/mL; P = 0.012) and IL-22 (37.5 ± 8.8 vs. 27.2 ± 3.7 pg/mL; P = 0.022) in ulcerative colitis were significantly higher than those in Crohn's disease ( Fig. 4C and E (Fig. 4E) . The serum TNF-α concentration was not different between the control and IBD groups (control group 21.5 ± 11.1 pg/mL; Crohn's disease group 21.6 ± 13.7 pg/mL; and ulcerative colitis group 16.3 ± 6.8 pg/mL; P = 0.917). 
DISCUSSION
In our study, the frequency of FOXP3 + Treg cells of LP in the terminal ileum of Crohn's disease was significantly higher than that in the control (Fig. 1) The frequency of RORγt + T cells that can differentiate to Th17 cell tended to be higher in inflamed mucosa of Crohn's disease than that in the control in the present study based on immunohistochemical staining (Fig. 3) . However, the difference between the two was not statistically significant. Although a few reports have suggested that Th17 cell infiltration in inflamed mucosa of IBD is increased, the result is based on polymerase chain reaction of mRNA of Th17 cells from inflamed mucosa, not based on immunohistochemical staining. 4, 10 Cytokines play crucial roles in the pathogenesis of IBD. 11 Results of serum cytokine analysis with the multiplex assay revealed that serum concentrations of IL-4, IL-21, IL-33, and IFN-γ in Crohn's disease were significantly lower than those in the control (Fig. 4A, D, F, and  G) . IL-4 and IL-33 are polarizing cytokines for the differentiating of naïve CD4 + T cells into Th2. 20, 21 Our results are similar to those of previous reports. 22, 23 West et al. 23 have revealed that serum IL-4 concentration is decreased in the LP mononuclear cells of inflamed tissue of IBD. Matsuure et al. 22 have reported selective resistance of mucosal T-cell activation to immunosuppression of IL-4 in Crohn's disease, but not in the control or ulcerative colitis. IFN-γ is a polarizing cytokine for differentiating of naïve CD4 + T cell into Th1. 1,24 IFN-γ, a pro-inflammatory cytokine playing a role in the pathogenesis of IBD, is increased in inflamed LP of Crohn's disease. 25 However, serum IFN-γ concentration in Crohn's disease was lower than that in the control in the present study (Fig. 4G) . The low serum IFN-γ concentration in this study might explain one of the reasons anti-IFN-γ therapy failed to treat Crohnn's disease in Reinisch 28 IL-33 as one member of IL-1 family is a proinflammatory cytokine produced by intestinal epithelial cells and sub-epithelical myofibroblasts. 11 It has been reported that the production of IL-33 of intestinal epithelial cells is increased in patients with ulcerative colitis, but not in patients with Crohn's disease. 29 In our study, serum concentration of IL-33 in the normal control was higher than that in Crohn's disease or ulcerative colitis (Fig. 4F) . The role of IL-33 has not been exactly evaluated yet in humans. The secretory function of IL-33 of intestinal epithelial cells might be decreased in the IBD patients. Further research could be performed.
Our results revealed that the serum concentration of IL-6 in Crohn's disease was significantly higher and tended to be higher in ulcerative colitis than that in the control (Fig. 4B) . IL-6 is produced by macrophages, fibroblasts, and T cells. 10 It is an important proinflammatory cytokine in IBD. It promotes differentiation of naïve CD4 + T cells to Th17 cell under the presence of TGF-β. 11,12
